Evolution of Gene Therapy for Ocular Diseases as Long-Acting Treatment
Time: 1:30 pm
day: Pre-Conference Workshop Day - WORKSHOP F
Details:
Gene therapies provide a lot of promise as long-acting treatment for ophthalmic diseases. Providing the retinal cells with the genetic information to reproduce the drug within the eye, gene therapies create a bio-factory, meaning that the drugs can last many years with a single injection. However, the field is still evolving and requires its bolts to be tightened and made foolproof.
Join this workshop to hear from leading experts in gene therapies for more insights on:
- Updates on clinical trials
- Are gene therapies the answer to achieving sustained release drug delivery?
- Where do gene therapy vectors transduce when they are injected into the suprachoroidal space?
